RECRUITING

Young Houston Emergency Opioid Engagement System

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

The Houston Emergency Response Opioid Engagement System for Youths and Adolescents (Young HEROES) is a community-based research program integrating assertive outreach, medication for opioid use disorder (MOUD), behavioral counseling, and peer recovery support. The objective is to compare differences in engagement and retention in treatment for individuals with opioid use disorder. The investigators also intend to understand the prevalence of opioid overdoses and OUD among youth in Houston.

Official Title

Houston Emergency Engagement System for Youths and Adolescents

Quick Facts

Study Start:2021-04-19
Study Completion:2027-08-31
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT04811014

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:13 Years to 17 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:CHILD
Inclusion CriteriaExclusion Criteria
  1. * In otherwise good health based on physician assessment and medical history
  2. * Drug screen positive for opioids
  3. * Patients express a willingness to stop opioid use
  4. * Meet Diagnostic and Statistical Manual of Mental Disorders - Text Revision (DSM-IV-TR) criteria for opioid dependence
  5. * Patients must be able to speak English
  6. * Be agreeable to and capable of signing the informed consent and assent (parent or guardian must consent, minor must assent)
  1. * Non-English-speaking patients
  2. * Have a known sensitivity to buprenorphine or naloxone
  3. * Be physiologically dependent on alcohol, benzodiazepines, or other drugs of abuse that require immediate medical attention. Other substance use diagnoses are not exclusionary.
  4. * Have a medical condition that would, in the opinion of the study physician, make participation medically hazardous, including unstable cardiovascular disease, neurological deficits, trauma, acute hepatitis, stroke, and liver or renal disease)
  5. * Be acutely psychotic, severely depressed, and in need of inpatient treatment, or is an immediate suicide risk
  6. * Be a nursing or pregnant female

Contacts and Locations

Study Contact

James R Langabeer, PhD
CONTACT
713-500-3925
james.r.langabeer@uth.tmc.edu
Meredith M O'Neal, MA
CONTACT
713-500-3624
meredith.m.oneal@uth.tmc.edu

Principal Investigator

James R Langabeer, PhD
PRINCIPAL_INVESTIGATOR
The University of Texas Health Science Center, Houston

Study Locations (Sites)

The University of Texas Health Science Center at Houston
Houston, Texas, 77030
United States

Collaborators and Investigators

Sponsor: The University of Texas Health Science Center, Houston

  • James R Langabeer, PhD, PRINCIPAL_INVESTIGATOR, The University of Texas Health Science Center, Houston

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2021-04-19
Study Completion Date2027-08-31

Study Record Updates

Study Start Date2021-04-19
Study Completion Date2027-08-31

Terms related to this study

Additional Relevant MeSH Terms

  • Opioid-use Disorder
  • Opioid Dependence
  • Opioid Overdose
  • Opioid Use
  • Substance Use Disorders